A hybrid lifestyle intervention delivered to people with obesity in Brazil’s public healthcare system did not increase the likelihood of achieving clinically meaningful weight loss when all participants were analysed, according to a randomised clinical trial published in JAMA Network.
Trial design and headline result
The trial enrolled 200 adults with obesity who were receiving care through Brazil’s public services. Participants were randomised to a hybrid-format programme — combining remote and in-person elements — or usual care. The main outcome was the proportion of people who lost at least 5% of their body weight.
In the intention-to-treat analysis, which includes all participants as originally assigned, the hybrid intervention did not produce a statistically greater chance of reaching the 5% weight-loss threshold compared with standard care. That means, at the primary level of analysis, the programme did not meet its principal target.
Signals in secondary and per-protocol analyses
Investigators report that secondary and per-protocol analyses — examining outcomes among those who adhered to the intervention — showed potential benefits for cardiometabolic markers. These analyses are narrower: they focus on participants who followed the programme to a predefined degree, rather than the whole group as randomised.
Such findings suggest the model may offer health advantages for people who engage with it consistently, even if the average effect across all participants was not significant. The authors emphasise that these are hypothesis-generating and require confirmation in further studies.
What this means for patients and services
For clinicians, public-health planners and patients the study offers a nuanced message. A mixed-format lifestyle programme — combining digital sessions with face-to-face support — is feasible within a publicly funded system and can be delivered at scale, but simply offering the programme does not guarantee population-level weight loss.
Key practical points to consider:
- Engagement matters: benefits appeared strongest among participants who adhered to the programme.
- Outcomes are multi-dimensional: weight change is one metric; improvements in blood pressure, glucose or lipid profiles may still occur even when weight loss is modest.
- Implementation influences impact: how services encourage attendance and sustained participation may determine real-world effectiveness.
Study data at a glance
| Item | Value |
|---|---|
| Participants randomised | 200 |
| Primary outcome | Proportion achieving ≥ 5% weight loss |
| Main finding (intention-to-treat) | No significant increase in reaching ≥ 5% weight loss |
| Secondary/per-protocol signal | Potential cardiometabolic benefits among adherent participants |
Context and next steps
Obesity remains a major long-term health challenge, linked to cardiovascular disease, diabetes and other conditions. Randomised trials such as this are valuable because they test how interventions perform in routine care settings rather than under tightly controlled conditions. The mixed findings here mirror a wider pattern in obesity research: multifaceted interventions can yield meaningful health gains for engaged participants, but scaling those effects across diverse populations is difficult.
Future research should examine which elements of hybrid programmes drive adherence and benefit, whether certain subgroups are most likely to respond, and how best to integrate behavioural support into public healthcare pathways. Trials with longer follow-up would also help determine whether early cardiometabolic changes translate into sustained health improvements.
For individuals seeking to manage weight or reduce cardiometabolic risk, the study reinforces two straightforward principles: interventions work best when people can take part regularly, and health gains are not limited to the number on the scales. Health professionals and service commissioners will need to consider how to boost engagement if hybrid delivery models are to fulfil their promise in public systems.
